Free tool
Diagnostics stocks
We cover 122 companies grouped under the Diagnostics theme. The median market value in the group is $78.37M. Across the group, the median move over the past trading day is 0.00%. 39% of the 120 with a 200-day average trade above it. Price change over the past year runs from −80.6% to +78.3% across the middle 80 percent of the group, with a median of −15.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
122 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $43.65 | +6.26% | −3.41% | −10.74% |
| QIA.DE | Qiagen N.V. | 36.41 EUR | −0.78% | −4.56% | −11.42% |
| 6869.T | Sysmex Corporation | 1,957.00 JPY | +19.66% | +29.29% | +5.65% |
| CAI | Caris Life Sciences, Inc. | $28.01 | +79.21% | +3.82% | −27.21% |
| SHL.AX | Sonic Healthcare Limited | 20.31 AUD | −7.72% | −7.74% | −11.60% |
| BLLN | BillionToOne, Inc. | $100.08 | −21.80% | +12.08% | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $26.25 | +16.46% | +64.99% | +107.18% |
| GRAL | GRAIL, Inc. | $82.54 | +23.62% | −7.12% | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $44.04 | −20.81% | +3.89% | +49.04% |
| CDNA | CareDx, Inc. | $50.80 | +39.71% | +165.41% | +298.43% |
| WGS | GeneDx Holdings Corp. | $87.41 | +44.38% | −33.93% | −28.28% |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% |
| NEO | NeoGenomics, Inc. | $16.79 | +27.78% | +42.77% | +160.31% |
| ALIF-B.ST | AddLife AB (publ) | 162.40 SEK | +0.74% | +8.24% | −7.56% |
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% |
| DIA.WA | Diagnostyka S.A. | 166.50 PLN | +0.54% | −3.70% | −17.53% |
| 4544.T | H.U. Group Holdings, Inc. | 3,678.00 JPY | +5.93% | +9.61% | +11.45% |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| 4694.T | BML, Inc. | 3,670.00 JPY | +1.66% | −2.27% | +7.64% |
| IDX.AX | Integral Diagnostics Limited | 2.40 AUD | +15.38% | −3.07% | −17.78% |
| DASA3.SA | Diagnósticos da América S.A. | 2.62 BRL | −8.07% | −41.52% | +111.29% |
| FLGT | Fulgent Genetics, Inc. | $19.95 | +1.89% | −22.04% | −7.34% |
| 137310.KS | SD Biosensor, Inc. | 6,260.00 KRW | +2.45% | −29.32% | −36.08% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,349.00 JPY | −4.59% | −1.31% | −2.85% |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | 2.89 AUD | +20.42% | +7.73% | +12.06% |
| VOX.WA | Voxel S.A. | 130.40 PLN | +2.68% | +7.24% | −20.15% |
| NIOX.L | NIOX Group Plc | 68.00 GBP | +11.48% | +0.03% | −6.05% |
| N3B.F | Anbio Biotechnology | 5.50 EUR | −36.78% | −67.46% | −86.59% |
| NNNN | Anbio Biotechnology | $7.83 | −23.08% | −73.44% | −84.06% |
| 197A.T | TAUNS LABORATORIES INC. | 503.00 JPY | +6.34% | −0.79% | −11.01% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| SBS.DE | Stratec SE | 22.35 EUR | +7.97% | +1.13% | −16.29% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −0.73% | −21.91% | +20.85% |
| BDSX | Biodesix, Inc. | $28.08 | +26.35% | +334.60% | +186.48% |
| MYGN | Myriad Genetics, Inc. | $3.19 | −41.47% | −48.05% | −45.84% |
| OSUR | OraSure Technologies, Inc. | $3.78 | −4.55% | +58.82% | +20.38% |
| ALERS.PA | Eurobio Scientific Société anonyme | 20.50 EUR | −3.76% | −15.11% | −18.97% |
| HLS.AX | Healius Limited | 0.43 AUD | +23.43% | −52.53% | −55.00% |
| 4595.T | Mizuho Medy Co.,Ltd. | 1,732.00 JPY | +3.34% | +0.06% | +13.41% |
| LUCD | Lucid Diagnostics Inc. | $1.01 | +11.85% | −9.82% | −12.93% |
| XGN | Exagen Inc. | $7.60 | +72.73% | +25.83% | −22.84% |
| PEB.AX | Pacific Edge Limited | 0.21 AUD | −6.82% | +28.12% | +64.00% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,862.00 JPY | +5.84% | +8.96% | +21.25% |
| S2B.WA | Syn2bio S.A. | 64.90 PLN | −5.94% | +81.79% | +81.79% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.44 | −5.53% | −37.99% | +78.31% |
| EKF.L | EKF Diagnostics Holdings plc | 25.40 GBP | −3.42% | −4.33% | −13.90% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| SCP.WA | Scope Fluidics S.A. | 139.80 PLN | +19.28% | 0.00% | −9.34% |
| S84.F | Scope Fluidics S.A. | 27.75 EUR | +19.87% | −25.90% | −9.76% |
| QUCY | Quantum Cyber N.V. | $1.36 | +23.64% | +17.24% | −20.93% |
| BNR | Burning Rock Biotech Limited | $9.80 | +4.26% | −50.20% | +13.95% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.60 SEK | −12.61% | −47.54% | −60.27% |
| BIOPOR.CO | BioPorto A/S | 1.20 DKK | −0.41% | +15.16% | −6.25% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.86 AUD | +29.55% | +3.64% | +67.65% |
| 7V0.DE | Novogenia AG | 6.10 EUR | −0.81% | −20.26% | −29.07% |
| 6678.T | Techno Medica Co., Ltd. | 2,082.00 JPY | +2.76% | −2.17% | +10.19% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.95 BRL | −8.39% | −36.56% | −52.27% |
| SERA | Sera Prognostics, Inc. | $2.18 | +6.34% | −27.33% | −17.42% |
| MDXH | MDxHealth SA | $0.79 | +88.71% | −77.00% | −83.84% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.11 AUD | +5.00% | −67.19% | −19.23% |
| DXR | Daxor Corporation | $10.00 | −2.06% | −30.36% | −7.83% |
| PRPO | Precipio, Inc. | $30.85 | +34.60% | +29.51% | +117.41% |
| ALKLH.PA | KLEA HOLDING | 0.16 EUR | −1.90% | −30.34% | −29.55% |
| CYC.AX | Cyclopharm Limited | 0.53 AUD | +0.96% | −46.70% | −47.50% |
| BIOBV.HE | Biohit Oyj | 2.56 EUR | −6.57% | −28.89% | −8.24% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.36 EUR | −1.67% | −38.54% | −47.32% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +14.60% | +22.38% | +8.44% |
| NCYT.L | Novacyt S.A. | 44.00 GBP | +20.55% | +22.39% | +9.18% |
| PAVM | PAVmed Inc. | $5.28 | +1.44% | −28.04% | −64.04% |
| ABDX.L | Abingdon Health Plc | 11.00 GBP | +11.68% | +71.87% | +100.00% |
| 2385.T | Soiken Holdings Inc. | 225.00 JPY | +4.17% | −5.06% | +16.58% |
| NXN.AX | Nexsen Ltd | 0.23 AUD | −14.81% | +53.33% | −17.86% |
| COV.AX | Cleo Diagnostics Ltd | 0.34 AUD | +6.25% | −44.72% | −5.56% |
| ACARIX.ST | Acarix AB (publ) | 0.23 SEK | −7.36% | −13.70% | −15.27% |
| MBX.TO | Microbix Biosystems Inc. | 0.30 CAD | −3.23% | +25.00% | +25.00% |
| GDR.L | genedrive plc | 1.38 GBP | +38.00% | +57.71% | +78.06% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −11.48% | +20.13% | −6.09% |
| MAP.AX | Microba Life Sciences Limited | 0.06 AUD | +14.58% | −28.57% | −42.11% |
| ALIKO.PA | Ikonisys S.A. | 1.46 EUR | −2.67% | −9.60% | −3.95% |
| RENX.L | Renalytix Plc | 4.25 GBP | +60.38% | −27.97% | −27.35% |
| RHY.AX | Rhythm Biosciences Limited | 0.10 AUD | +22.78% | −22.40% | −3.00% |
| 6090.T | Human Metabolome Technologies, Inc. | 637.00 JPY | +7.24% | −4.93% | −14.95% |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.17 AUD | +6.45% | −77.08% | −48.44% |
| ALBIO.PA | Biosynex SA | 0.92 EUR | −0.43% | +58.48% | −22.70% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −80.77% |
| URT.WA | Urteste S.A. | 43.50 PLN | +0.93% | +2.35% | −14.03% |
| BDX.AX | BCAL Diagnostics Limited | 0.05 AUD | −26.76% | −48.00% | −17.46% |
| IIQ.AX | INOVIQ Ltd | 0.18 AUD | −7.89% | −56.25% | −56.25% |
| GMT.WA | Genomtec S.A. | 3.75 PLN | −6.60% | −0.53% | −38.02% |
| ADVB | Advanced Biomed Inc. | $9.18 | −36.07% | +51.99% | −4.38% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.44 SEK | −12.60% | +1.39% | −33.59% |
| GSS.AX | Genetic Signatures Limited | 0.08 AUD | +38.33% | −66.12% | −72.33% |
| TRI.AX | TrivarX Limited | 0.02 AUD | −5.88% | −20.00% | +77.78% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.21 SEK | −8.29% | −39.20% | −46.85% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.60% | −17.89% | −22.30% |
| AT1.AX | Atomo Diagnostics Limited | 0.02 AUD | 0.00% | −57.50% | −15.00% |
| GENI.L | GENinCode Plc | 0.88 GBP | +6.06% | −63.54% | −37.50% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.62 SEK | +18.73% | −81.05% | −87.29% |
| CODX | Co-Diagnostics, Inc. | $1.23 | −39.71% | −77.88% | −87.07% |
| ACON | Aclarion, Inc. | $2.49 | +12.16% | −50.00% | −65.89% |
| OBD.L | Oxford BioDynamics Plc | 0.13 GBP | 0.00% | −48.00% | −72.63% |
| INBS | Intelligent Bio Solutions Inc. | $2.36 | +37.21% | −70.09% | −83.95% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| NDRA | ENDRA Life Sciences Inc. | $4.75 | −0.63% | +10.72% | +6.74% |
| AIDX | 20/20 Biolabs, Inc. | $0.53 | +17.38% | −97.79% | −97.79% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.91 | +17.90% | −32.75% | −45.58% |
| BMRA | Biomerica, Inc. | $1.77 | +9.26% | −30.04% | −48.40% |
| VNRX | VolitionRx Limited | $0.38 | −56.30% | −92.88% | −97.21% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | +0.91% | −64.98% | −65.85% |
| REVB | Revelation Biosciences, Inc. | $1.00 | −5.66% | −69.25% | −91.21% |
| BIAF | bioAffinity Technologies, Inc. | $5.19 | +661.00% | +325.41% | −30.52% |
| ADTX | Aditxt, Inc. | $0.00 | −48.00% | −100.00% | −100.00% |
| ONCO | Onconetix, Inc. | $0.64 | −21.01% | −99.20% | −99.57% |
| VRAX | Virax Biolabs Group Limited | $2.91 | −6.13% | +657.81% | +275.97% |
| 2CUREX.ST | 2cureX AB (publ) | 0.51 SEK | −71.95% | −5.02% | −79.23% |
| BJDX | Bluejay Diagnostics, Inc. | $0.92 | −16.71% | −65.03% | −83.87% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.